## Abstract The data show that in chronic lymphocytic leukemia (CLL) there are elevated numbers of peripheral blood lymphocytes (PBL) capable of rosette formation (complement‐rosetting lymphocytes, CRL) with bacteria (B)‐antibody‐(A)‐complement (C) (BAC) complexes. In most of the CLL patients studi
Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?
✍ Scribed by Øystein Bruserud; Karl Johan Tronstad; Emmet McCormack; Bjørn Tore Gjertsen
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 256 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The development of either histiocytic lymphoma or Hodgkin disease in association with pre-existing chronic lymphocytic leukemia has been described in the literature as a terminal event. We describe two patients in whom the diagnosis of a second malignant lymphoma was made during life and who achieve
## Abstract Gene profiling studies of patients with chronic lymphocytic leukemia (CLL) has revealed increased expression of Ror1, a cell surface receptor tyrosine kinase. The aim of present study was to analyze gene and protein expression of Ror1 in CLL cells and normal blood leukocytes. Gene expre